Recent Administration of Iodinated Contrast Renders Core Infarct Estimation Inaccurate Using RAPID Software.


Journal

AJNR. American journal of neuroradiology
ISSN: 1936-959X
Titre abrégé: AJNR Am J Neuroradiol
Pays: United States
ID NLM: 8003708

Informations de publication

Date de publication:
12 2020
Historique:
received: 24 01 2020
accepted: 01 08 2020
pubmed: 21 11 2020
medline: 9 3 2021
entrez: 20 11 2020
Statut: ppublish

Résumé

Automated CTP software is increasingly used for extended window emergent large-vessel occlusion to quantify core infarct. We aimed to assess whether RAPID software underestimates core infarct in patients with an extended window recently receiving IV iodinated contrast. We reviewed a prospective, single-center data base of 271 consecutive patients who underwent CTA ± CTP for acute ischemic stroke from May 2018 through January 2019. Patients with emergent large-vessel occlusion confirmed by CTA in the extended window (>6 hours since last known well) and CTP with RAPID postprocessing were included. Two blinded raters independently assessed CT ASPECTS on NCCT performed at the time of CTP. RAPID software used relative cerebral blood flow of <30% as a surrogate for irreversible core infarct. Patients were dichotomized on the basis of receiving recent IV iodinated contrast (<8 hours before CTP) for a separate imaging study. The recent IV contrast and contrast-naïve cohorts comprised 23 and 15 patients, respectively. Multivariate linear regression analysis demonstrated that recent IV contrast administration was independently associated with a decrease in the RAPID core infarct estimate (proportional increase = 0.34; 95% CI, 0.12-0.96; Patients who received IV iodinated contrast in proximity (<8 hours) to CTA/CTP as part of a separate imaging study had a much higher likelihood of core infarct underestimation with RAPID compared with contrast-naïve patients. Over-reliance on RAPID postprocessing for treatment disposition of patients with extended window emergent large-vessel occlusion should be avoided, particularly with recent IV contrast administration.

Sections du résumé

BACKGROUND AND PURPOSE
Automated CTP software is increasingly used for extended window emergent large-vessel occlusion to quantify core infarct. We aimed to assess whether RAPID software underestimates core infarct in patients with an extended window recently receiving IV iodinated contrast.
MATERIALS AND METHODS
We reviewed a prospective, single-center data base of 271 consecutive patients who underwent CTA ± CTP for acute ischemic stroke from May 2018 through January 2019. Patients with emergent large-vessel occlusion confirmed by CTA in the extended window (>6 hours since last known well) and CTP with RAPID postprocessing were included. Two blinded raters independently assessed CT ASPECTS on NCCT performed at the time of CTP. RAPID software used relative cerebral blood flow of <30% as a surrogate for irreversible core infarct. Patients were dichotomized on the basis of receiving recent IV iodinated contrast (<8 hours before CTP) for a separate imaging study.
RESULTS
The recent IV contrast and contrast-naïve cohorts comprised 23 and 15 patients, respectively. Multivariate linear regression analysis demonstrated that recent IV contrast administration was independently associated with a decrease in the RAPID core infarct estimate (proportional increase = 0.34; 95% CI, 0.12-0.96;
CONCLUSIONS
Patients who received IV iodinated contrast in proximity (<8 hours) to CTA/CTP as part of a separate imaging study had a much higher likelihood of core infarct underestimation with RAPID compared with contrast-naïve patients. Over-reliance on RAPID postprocessing for treatment disposition of patients with extended window emergent large-vessel occlusion should be avoided, particularly with recent IV contrast administration.

Identifiants

pubmed: 33214184
pii: ajnr.A6908
doi: 10.3174/ajnr.A6908
pmc: PMC7963234
doi:

Substances chimiques

Contrast Media 0
Iodine Compounds 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2235-2242

Subventions

Organisme : NIDCD NIH HHS
ID : R21 DC016087
Pays : United States
Organisme : NHLBI NIH HHS
ID : R56 HL149124
Pays : United States
Organisme : NINDS NIH HHS
ID : U54 NS065705
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

© 2020 by American Journal of Neuroradiology.

Références

Stroke. 2016 Sep;47(9):2318-22
pubmed: 27507858
Int J Stroke. 2015 Apr;10(3):429-38
pubmed: 25546514
Neuroradiology. 2012 Feb;54(2):105-12
pubmed: 21344216
Stroke. 2017 Apr;48(4):932-938
pubmed: 28283606
J Comput Assist Tomogr. 1984 Oct;8(5):936-9
pubmed: 6432864
AJNR Am J Neuroradiol. 2008 Jun;29(6):1118-23
pubmed: 18403559
J Neuroimaging. 2004 Jan;14(1):42-8
pubmed: 14748207
Stroke. 2006 Apr;37(4):979-85
pubmed: 16514093
Stroke. 2001 Sep;32(9):2042-8
pubmed: 11546895
J Neurointerv Surg. 2020 Apr;12(4):350-355
pubmed: 31401563
Stroke. 2019 Sep;50(9):2404-2412
pubmed: 31345135
Radiographics. 2006 Oct;26 Suppl 1:S75-95
pubmed: 17050521
AJNR Am J Neuroradiol. 2012 Oct;33(9):1791-6
pubmed: 22538076
Stroke. 2019 Oct;50(10):2783-2789
pubmed: 31462191
J Neurointerv Surg. 2019 Dec;11(12):1249-1256
pubmed: 31203208
AJNR Am J Neuroradiol. 2014 May;35(5):884-90
pubmed: 24371030
Stroke. 2014 Mar;45(3):746-51
pubmed: 24503670
Interv Neuroradiol. 2014 Jan-Feb;20(1):106-15
pubmed: 24556308
J Neurointerv Surg. 2017 Jan;9(1):66-69
pubmed: 27566491
Int J Stroke. 2015 Apr;10(3):439-48
pubmed: 25777831
Cerebrovasc Dis. 2002;13(1):47-56
pubmed: 11810011
AJNR Am J Neuroradiol. 2006 Oct;27(9):1990-5
pubmed: 17032881
Front Neurol. 2017 Jan 12;7:245
pubmed: 28127292
J Stroke Cerebrovasc Dis. 2015 Oct;24(10):2306-12
pubmed: 26187789
Int J Stroke. 2017 Oct;12(8):896-905
pubmed: 28946832
N Engl J Med. 2018 Jan 4;378(1):11-21
pubmed: 29129157
J Cereb Blood Flow Metab. 2016 Oct;36(10):1780-1789
pubmed: 26661203
Radiology. 1999 Oct;213(1):150-5
pubmed: 10540655
Clin Radiol. 2006 Feb;61(2):156-62
pubmed: 16439221
Stroke. 2011 Dec;42(12):3435-40
pubmed: 21980202
Int J Stroke. 2015 Jun;10(4):619-26
pubmed: 24206399

Auteurs

A Z Copelan (AZ)

From the Departments of Diagnostic and Interventional Neuroradiology (A.Z.C., E.R.S., G.T.D., K.H.N., D.M., R.S.K., Z.J.H., A.A.A., W.P.D., C.F.D., R.T.H., V.V.H., S.W.H., D.L.C., J.N., D.M., M.C., M.R.A.).

E R Smith (ER)

From the Departments of Diagnostic and Interventional Neuroradiology (A.Z.C., E.R.S., G.T.D., K.H.N., D.M., R.S.K., Z.J.H., A.A.A., W.P.D., C.F.D., R.T.H., V.V.H., S.W.H., D.L.C., J.N., D.M., M.C., M.R.A.).
Department of Radiology (E.R.S.), Medical College of Wisconsin, Milwaukee, Wisconsin.

G T Drocton (GT)

From the Departments of Diagnostic and Interventional Neuroradiology (A.Z.C., E.R.S., G.T.D., K.H.N., D.M., R.S.K., Z.J.H., A.A.A., W.P.D., C.F.D., R.T.H., V.V.H., S.W.H., D.L.C., J.N., D.M., M.C., M.R.A.).

K H Narsinh (KH)

From the Departments of Diagnostic and Interventional Neuroradiology (A.Z.C., E.R.S., G.T.D., K.H.N., D.M., R.S.K., Z.J.H., A.A.A., W.P.D., C.F.D., R.T.H., V.V.H., S.W.H., D.L.C., J.N., D.M., M.C., M.R.A.).

D Murph (D)

From the Departments of Diagnostic and Interventional Neuroradiology (A.Z.C., E.R.S., G.T.D., K.H.N., D.M., R.S.K., Z.J.H., A.A.A., W.P.D., C.F.D., R.T.H., V.V.H., S.W.H., D.L.C., J.N., D.M., M.C., M.R.A.).

R S Khangura (RS)

From the Departments of Diagnostic and Interventional Neuroradiology (A.Z.C., E.R.S., G.T.D., K.H.N., D.M., R.S.K., Z.J.H., A.A.A., W.P.D., C.F.D., R.T.H., V.V.H., S.W.H., D.L.C., J.N., D.M., M.C., M.R.A.).

Z J Hartley (ZJ)

From the Departments of Diagnostic and Interventional Neuroradiology (A.Z.C., E.R.S., G.T.D., K.H.N., D.M., R.S.K., Z.J.H., A.A.A., W.P.D., C.F.D., R.T.H., V.V.H., S.W.H., D.L.C., J.N., D.M., M.C., M.R.A.).

A A Abla (AA)

From the Departments of Diagnostic and Interventional Neuroradiology (A.Z.C., E.R.S., G.T.D., K.H.N., D.M., R.S.K., Z.J.H., A.A.A., W.P.D., C.F.D., R.T.H., V.V.H., S.W.H., D.L.C., J.N., D.M., M.C., M.R.A.).
Neurosurgery (A.A.A.), University of California, San Francisco, San Francisco, California.

W P Dillon (WP)

From the Departments of Diagnostic and Interventional Neuroradiology (A.Z.C., E.R.S., G.T.D., K.H.N., D.M., R.S.K., Z.J.H., A.A.A., W.P.D., C.F.D., R.T.H., V.V.H., S.W.H., D.L.C., J.N., D.M., M.C., M.R.A.).

C F Dowd (CF)

From the Departments of Diagnostic and Interventional Neuroradiology (A.Z.C., E.R.S., G.T.D., K.H.N., D.M., R.S.K., Z.J.H., A.A.A., W.P.D., C.F.D., R.T.H., V.V.H., S.W.H., D.L.C., J.N., D.M., M.C., M.R.A.).

R T Higashida (RT)

From the Departments of Diagnostic and Interventional Neuroradiology (A.Z.C., E.R.S., G.T.D., K.H.N., D.M., R.S.K., Z.J.H., A.A.A., W.P.D., C.F.D., R.T.H., V.V.H., S.W.H., D.L.C., J.N., D.M., M.C., M.R.A.).

V V Halbach (VV)

From the Departments of Diagnostic and Interventional Neuroradiology (A.Z.C., E.R.S., G.T.D., K.H.N., D.M., R.S.K., Z.J.H., A.A.A., W.P.D., C.F.D., R.T.H., V.V.H., S.W.H., D.L.C., J.N., D.M., M.C., M.R.A.).

S W Hetts (SW)

From the Departments of Diagnostic and Interventional Neuroradiology (A.Z.C., E.R.S., G.T.D., K.H.N., D.M., R.S.K., Z.J.H., A.A.A., W.P.D., C.F.D., R.T.H., V.V.H., S.W.H., D.L.C., J.N., D.M., M.C., M.R.A.).

D L Cooke (DL)

From the Departments of Diagnostic and Interventional Neuroradiology (A.Z.C., E.R.S., G.T.D., K.H.N., D.M., R.S.K., Z.J.H., A.A.A., W.P.D., C.F.D., R.T.H., V.V.H., S.W.H., D.L.C., J.N., D.M., M.C., M.R.A.).

K Keenan (K)

Department of Neurology (K.K.), University of California Davis, Sacramento, California.

J Nelson (J)

From the Departments of Diagnostic and Interventional Neuroradiology (A.Z.C., E.R.S., G.T.D., K.H.N., D.M., R.S.K., Z.J.H., A.A.A., W.P.D., C.F.D., R.T.H., V.V.H., S.W.H., D.L.C., J.N., D.M., M.C., M.R.A.).

D Mccoy (D)

From the Departments of Diagnostic and Interventional Neuroradiology (A.Z.C., E.R.S., G.T.D., K.H.N., D.M., R.S.K., Z.J.H., A.A.A., W.P.D., C.F.D., R.T.H., V.V.H., S.W.H., D.L.C., J.N., D.M., M.C., M.R.A.).

M Ciano (M)

From the Departments of Diagnostic and Interventional Neuroradiology (A.Z.C., E.R.S., G.T.D., K.H.N., D.M., R.S.K., Z.J.H., A.A.A., W.P.D., C.F.D., R.T.H., V.V.H., S.W.H., D.L.C., J.N., D.M., M.C., M.R.A.).

M R Amans (MR)

From the Departments of Diagnostic and Interventional Neuroradiology (A.Z.C., E.R.S., G.T.D., K.H.N., D.M., R.S.K., Z.J.H., A.A.A., W.P.D., C.F.D., R.T.H., V.V.H., S.W.H., D.L.C., J.N., D.M., M.C., M.R.A.) Matthew.amans@ucsf.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH